Evidence map›Paper›PMID 21994326›Full record

ArticleThe Journal of general virology2012

Genomic and antigenic characterization of Jos virus.

Ana Valeria Bussetti, Gustavo Palacios, Amelia Travassos da Rosa, Nazir Savji, Komal Jain, Hilda Guzman, Stephen Hutchison, Vsevolod L Popov, Robert B Tesh, W Ian Lipkin

Abstract read
In one paragraph

Article in The Journal of general virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Tick-Borne Viruses.Virologica Sinica · 2018
    Review
  9. Bourbon Virus in Field-Collected Ticks, Missouri, USA.Emerging infectious diseases · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ana Valeria BussettiCenter for Infection and Immunity and WHO Collaborating Centre for Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases, Mailman School of Public Health, Columbia University, New York, NY, USA.
Gustavo PalaciosCenter for Infection and Immunity and WHO Collaborating Centre for Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases, Mailman School of Public Health, Columbia University, New York, NY, USA.
Amelia Travassos da RosaCenter for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Nazir SavjiCenter for Infection and Immunity and WHO Collaborating Centre for Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases, Mailman School of Public Health, Columbia University, New York, NY, USA.
Komal JainCenter for Infection and Immunity and WHO Collaborating Centre for Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases, Mailman School of Public Health, Columbia University, New York, NY, USA.
Hilda GuzmanCenter for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Stephen Hutchison454 Life Sciences, A Roche Company, Branford, CT, USA.
Vsevolod L PopovCenter for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Robert B TeshCenter for Biodefense and Emerging Infectious Diseases, Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
W Ian LipkinCenter for Infection and Immunity and WHO Collaborating Centre for Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases, Mailman School of Public Health, Columbia University, New York, NY, USA.
The University of Texas Medical Branch at Galveston · USNational Center for Emerging and Zoonotic Infectious Diseases · USColumbia University · USEnzo Life Sciences (United States) · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
U.S. Based Collaboration in Emerging Viral and Prion Diseases-26625489N01AI025489 · NIAID · University of Texas Medical Branch · 2004 to 2004
–
NIAID NIH HHS AI57158NIAID NIH HHS HHSN272201000040CNIAID NIH HHS HHSN272201000040INIAID NIH HHS N01 AI025489NIAID NIH HHS N01-AI25489NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

Jos virus (JOSV), originally isolated in Jos, Nigeria in 1967, has remained unclassified despite cultivation in tissue culture, development of animal models of infection and implementation of seroprevalence surveys for infection. Here, we report genetic, ultrastructural and serological evidence that JOSV is an orthomyxovirus distinct from but phylogenetically related to viruses of the genus Thogotovirus.

Indexed as

Genome, ViralAnimalsAntigens, ViralCluster AnalysisMiceMicroscopy, Electron, TransmissionMolecular Sequence DataNigeriaPhylogenyRNA, ViralSequence Analysis, DNAThogotovirusViral ProteinsVirionAntigens, ViralRNA, ViralViral Proteins

Identifiers

PMID21994326
PMCPMC3352346
OpenAlexW2060001430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.